Quick Answer
iSpecimen Inc. reported Cash And Cash Equivalents At Carrying Value of $1.88 million for the year ending 2024.
- iSpecimen Inc. showed a decrease of -19.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from iSpecimen Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $13.18 million | Q3 2021: $9.79 million | Q1 2022: $26.10 million | Q2 2022: $23.69 million | Q3 2022: $20.66 million | Q1 2023: $3.76 million | Q2 2023: $2.00 million | Q3 2023: $2.72 million | Q1 2024: $2.09 million | Q2 2024: $2.15 million | Q3 2024: $1.75 million.
- Over the full 5 years of available data (2020 to 2024), iSpecimen Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 169.9%.
- Historical annual values: Fiscal year 2024: $1.88 million | Fiscal year 2023: $2.34 million | Fiscal year 2022: $15.31 million | Fiscal year 2021: $27.74 million | Fiscal year 2020: $695.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: